SF Capital Partners

SF Capital Partners is a private investment firm that specializes in the life sciences, biotechnology, and healthcare sectors. The firm is primarily known for its strategic investments in clinical-stage biotechnology companies, often participating in Private Investment in Public Equity (PIPE) transactions and other structured financing rounds. SF Capital Partners focuses on identifying companies with innovative therapeutic platforms and high-potential drug candidates, particularly in the areas of oncology, ophthalmology, and rare diseases. By providing growth capital, the firm supports the advancement of clinical trials and the commercialization of novel medical treatments. SF Capital Partners maintains a portfolio of diverse healthcare assets and is recognized for its role in funding emerging biotech entities.